Edition:
United States

People: Impax Laboratories Inc (IPXL.OQ)

IPXL.OQ on NASDAQ Stock Exchange Global Select Market

14.60USD
17 Feb 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$14.60
Open
$14.55
Day's High
$14.70
Day's Low
$14.35
Volume
150,881
Avg. Vol
296,563
52-wk High
$37.18
52-wk Low
$11.65

Schlossberg, Mark 

Mr. Mark A. Schlossberg Esq is Senior Vice President, General Counsel, Corporate Secretary of Impax Laboratories Inc. He has served as our Senior Vice President, General Counsel and Corporate Secretary since May 2011. Prior to joining us, he served as Vice President, Associate General Counsel of Amgen Inc. from September 2004 to May 2011. Prior to joining Amgen, he held legal and business positions at Medtronic, Inc., and legal positions at Diageo plc, RJR Nabisco, Inc. and Mudge Rose Guthrie Alexander & Ferdon. He earned a Bachelor of Sciences in business administration, finance from the University of Southern California and a Juris Doctor degree from Emory University.

Basic Compensation

Total Annual Compensation, USD 877,809
Restricted Stock Awards, USD 814,000
Long-Term Incentive Plans, USD --
All Other, USD 858,905
Fiscal Year Total, USD 2,550,710

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Burr

415,023

J. Kevin Buchi

--

Bryan Reasons

3,015,360

Douglas Boothe

--

Michael Nestor

2,578,790

Mark Schlossberg

2,550,710
As Of  30 Dec 2015